Covina, CA, June 10, 2020 (GLOBE NEWSWIRE) -- The global generic sterile injectables market accounted for US$ 68.7 billion in 2019 and is estimated to be US$ 196.2 billion by 2029 and is anticipated to register a CAGR of 11.2%.
The report "Global Generic Sterile Injectables Market, By Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulin, Blood Factors, Antibiotics, and Others), By Therapeutic Application (Cancer, Diabetes, Cardiovascular Disease, Central Nervous System, Musculoskeletal System, and Others), By Distribution Channel (Hospitals, Drug Stores, and Retail Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029”.
Key Highlights:
- In August 2017 Athenex, Inc. introduced three previously disclosed sterile injectable molecules through its subsidiary Athenex Pharma Solutions (APS). They are Norepinephrine, Epinephrine, and Phenylephrine.
- In May 2018, Mithra entered into a contract agreement with Midas Pharma for manufacturing sterile injectable product at the Mithra CDMO.
- In August 2018, Nevakar Inc., entered into an exclusive licensing agreement with Endo International plc’s subsidiary, Endo Ventures Limited. This aimed for the development of five differentiated, sterile injectable products in the U.S. and Canada.
Request a Sample Copy of the Market Report @ https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4277
Analyst View:
Growing prevalence of cancer worldwide
Increasing prevalence of chronic illnesses particularly cancer across the world is expected to drive the demand for sterile injectable drugs in the coming years. In addition, growing number of drug manufacturers focusing on the production of drugs to treat cancer is also propelling growth of the target market. Further, rapid FDA approvals of sterile injectable drugs coupled with shortened approval times for new drug development in cancer cure is enhancing to dive drug supplies and is ultimately fueling demand in the global generic sterile injectables market.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Generic Sterile Injectables Market”, By Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulin, Blood Factors, Antibiotics, and Others), By Therapeutic Application (Cancer, Diabetes, Cardiovascular Disease, Central Nervous System, Musculoskeletal System, and Others), By Distribution Channel (Hospitals, Drug Stores, and Retail Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029
Request for a Discount on the Current Pricing @ https://www.prophecymarketinsights.com/market_insight/Insight/request-discount/4277
Key Market Insights from the report:
The global generic sterile injectables market accounted for US$ 68.7 billion in 2019 and is estimated to be US$ 196.2 billion by 2029 and is anticipated to register a CAGR of 11.2%. The market report has been segmented on the basis of drug type, therapeutic application, distribution channel, and region.
- By drug type, the global generic sterile injectables market is segmented into monoclonal antibodies, cytokines, insulin, peptide hormones, vaccines, immunoglobulin, blood factors, antibiotics, and others.
- By therapeutic application, the use of injectable drugs in oncology is projected to increase at high rates in North America owing to growth in cases of oncology. As per National Cancer Institute, the cancer cases has raised at the rate of 13.1% from 2012 to 2016.
- By distribution channel, the target market is segmented into hospitals, drug stores, and retail pharmacies
- By region, North America market is projected to lead the global market in terms of revenue and is predicted to maintain its position in the coming years. The governance can be attributed to favorable reimbursement policies, well-developed healthcare infrastructure, and presence of major players working in the countries in this region.
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Generic-Sterile-Injectables-Market-4277
Competitive Landscape:
The prominent player operating in the global generic sterile injectables market includes Sun Pharmaceutical Industries, Ltd., Aspen Pharmacare Holding, Ltd., Lupin Limited, Cipla Pharmaceuticals, Inc., Fresenius Kabi, AuroMedics Pharma LLC, Valeant Pharmaceuticals, Inc., Kay Pharma, CSC Pharmaceuticals, Inc., and Reddys Laboratories Limited
The market provides detailed information regarding industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory framework across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included into the report.
About Prophecy Market Insights
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
Some Important Points Answered in this Market Report Are Given Below:
- COVID-19 impact on the market, detailed analysis on economic, health and financial structure.
- Explains an overview of the product portfolio, including product development, planning, and positioning
- Explains details about key operational strategies with focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
- Detailed analysis of the market revenue over the forecasted period.
- Examining various outlooks of the market with the help of Porter’s five forces Analysis, PEST & SWOT Analysis.
- Study on the segments that are anticipated to dominate the market.
- Study on the regional analysis that is expected to register the highest growth over the forecast period
Key Topics Covered
- Introduction
- Study Deliverables
- Study Assumptions
- Scope of the Study
- Research Methodology
- Executive Summary
- Opportunity Map Analysis
- Market at Glance
- Market Share (%) and BPS Analysis, by Region
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Investment Analysis
- Competitive Analysis
A look at the Related Reports,
- Global Facial Injectables Market
- Global Alopecia Treatment Market
- Global Multiple Sclerosis Therapeutics Market
- Global NonInsulin Therapies for Diabetes Market